Current Domperidone + Current proton pump inhibitor (PPI)
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Arrhythmias, Cardiac
Conditions
Arrhythmias, Cardiac
Trial Timeline
Mar 1, 2007 → Mar 1, 2009
NCT ID
NCT00925457About Current Domperidone + Current proton pump inhibitor (PPI)
Current Domperidone + Current proton pump inhibitor (PPI) is a pre-clinical stage product being developed by Johnson & Johnson for Arrhythmias, Cardiac. The current trial status is completed. This product is registered under clinical trial identifier NCT00925457. Target conditions include Arrhythmias, Cardiac.
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00925457 | Pre-clinical | Completed |
Competing Products
2 competing products in Arrhythmias, Cardiac
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Risk of selected safety events | AstraZeneca | Pre-clinical | 26 |
| Double-blind investigational anti-arrhythmic + GAP-486 | Pfizer | Phase 2 | 27 |